Aduro BioTech's Series C Round

Aduro BioTech raised a round of funding on June 11, 2014.

Aduro is advancing multiple therapeutic and prophylactic vaccines for cancer and infectious diseases based on its attenuated Listeria monocytogenes vaccine platforms. The company is also advancing a n…

Articles about Aduro BioTech's Series C Round: